Choriogonadotropin Alfa 相關新聞
Choriogonadotropin Alfa 目前有 0 則相關新聞報導,預測適應症 20 個。
本頁整合 Choriogonadotropin Alfa 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
- 原適應症:Ovitrelle is indicated in the treatment of: women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilisation (IVF): Ovitrelle is administered to trigger final...
- 證據等級:L5
- 預測適應症(20 個):
- peptic esophagitis(98.4%)
- postural orthostatic tachycardia syndrome(98.3%)
- esophageal disease(97.6%)
- Raynaud disease(97.4%)
- non-syndromic esophageal malformation(96.9%)
- esophageal ulcer(96.8%)
- His bundle tachycardia(96.0%)
- sinoatrial block(95.9%)
- progressive familial heart block(95.7%)
- sinoatrial node disease(95.5%)
- restless legs syndrome(95.4%)
- esophageal atresia (disease)(95.3%)
- active peptic ulcer disease(95.3%)
- gastrojejunal ulcer(95.3%)
- peptic ulcer perforation(95.3%)
- migraine disorder(95.3%)
- esophageal leukoplakia (disease)(95.2%)
- acne (disease)(95.2%)
- dyskinesia of esophagus(95.2%)
- esophageal diverticulosis(95.2%)
相關新聞(0 則)
目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。
免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。